Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Addict Behav. 2019 May 3;96:68–75. doi: 10.1016/j.addbeh.2019.04.017

Table 2.

. Bivariate comparisons among risky drinkers at baseline (N=106), comparing individuals with persistent risky drinking and individualswith improved drinkingat 1-year follow-up.

Persistent Risky
Drinking (n=68)
Mean/SD or n(%)
Improved Drinking
(n=38)
Mean/SD or n(%)
t(df) or X2 (df)
or
P
Age 32.6 +/−11.1 31.8 +/− 11.6 0.35 (104) NS
Sex assigned at birth 8.27(1) 0.004
Female 48 (70.6) 16 (42.1)
Male 20 (29.4) 22 (57.9)
Race/Ethnicity 10.02 (3) 0.02
White, non-Hispanic 39 (57.3) 12 (31.6)
Hispanic/Latino 5 (7.4) 10 (26.3)
African American 9 (13.2) 7 (18.4)
Other 15 (22.1) 9 (23.7)
Annual household income ≤2× 2016 US DHHS Poverty Guideline 25 (36.8) 23 (60.5) 5.26 (1) 0.02
Educational attainment 0.02 (1) NS
High school or less 10 (14.7) 6 (15.8)
Some college or more 58 (85.3) 32 (84.2)
Relationship status 0.19 (1) NS
Single 31 (45.6) 19 (50.0)
In a relationship 37 (54.4) 19 (50.0)
Enacted stigma 3.01 +/− 2.65 2.68 +/− 2.54 0.63 (104) NS
Felt stigma 4.99 +/− 0.98 5.10 +/− 0.82 −0.59 (104) NS
Time since changing gender role/expression (years) 7.70 (2) 0.02
Milestone not met or <1 11 (16.2) 5 (13.2)
1–5 21 (30.9) 22 (57.9)
>5 36 (52.9) 11 (28.9)
Current gender-affirming psychotherapy 20 (29.4) 17 (44.7) 2.52 (1) NS
Current gender-affirming hormone 44 (64.7) 28 (73.7) 0.90(1) NS
Lifetime gender- affirming surgery 35 (51.5) 16 (42.1) 0.86 (1) NS
T rans gender congruence score 5.00 +/− 1.15 4.93 +/− 1.07 0.31 (104) NS
Social support 5.30 +/− 1.01 5.15 +/− 1.06 0.72 (104) NS
Identity style
Informational 2.13 +/− 0.60 2.30 +/− 0.87 −1.15 (104) NS
Normative 4.14 +/− 0.59 4.25 +/− 0.55 −0.99 (104) NS
Diffuse-avoidant 1.91 +/− 0.44 2.17 +/− 0.74 −2.21 (104) 0.03
Past-year alcohol/drug treatment 8 (11.8) 4 (10.5) 0.37 (1) NS

Note:All measures refer to baseline measures except “Identity Style” and “Current alcohol/drug treatment,” which were only assessed at 1-year follow-up.

NS: Not significant